Anthem Biosciences: Premium CRDMO but at Nosebleed Valuation
Moneylife Digital Team 23 July 2026
The global contract research, development and manufacturing organisation (CRDMO) industry was valued at approximately US$213bn (billion) in 2024 and is expected to reach US$330bn by 2029, implying...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback